longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

Moderna

MRNA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
  • Weekly Recap | Moderna -4.46%, Citi cuts to Sell

    Weekly Review·Oct 3, 2026 at 07:17 AM
    MRNA+4.81%MRNY+3.90%
  • Weekly Recap | Moderna +29.11%, closing in on record highs

    Weekly Review·Sep 26, 2026 at 06:45 AM
    MRNA+4.81%MRNY+3.90%
  • Weekly Recap | Moderna +6.99%, cancer vaccine in focus

    Weekly Review·Sep 19, 2026 at 06:27 AM
    MRNA+4.81%MRNY+3.90%
  • Weekly Recap | Moderna -1.09%, tumour vaccine milestone

    Weekly Review·Sep 12, 2026 at 06:22 AM
    MRNA+4.81%MRNY+3.90%
  • Weekly Recap | Moderna +5.48%, consensus target below spot

    Weekly Review·Sep 5, 2026 at 07:36 AM
    MRNA+4.81%MRNY+3.90%
  • Weekly Recap | Moderna -4.92%, convertible offering weighs

    Weekly Review·Aug 29, 2026 at 06:02 AM
    MRNA+4.81%MRNY+3.90%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy